Insiders Trades

★ Sign in to follow

DM

David M. Hall

RepliCel Life Sciences Inc.

Cumul. flow

Total declarations

17

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€17k

Latest filing published 05 Dec 2024 for RepliCel Life Sciences Inc..

Insider track record

Disclosed buys

0

Disclosed sells

1

Signal history

David M. Hall: trading record in brief

David M. Hall is a declared insider of RepliCel Life Sciences Inc., with filings sourced from SEDI. In total, 17 filings cover trades dated from 22 December 2010 to 26 November 2024.

Sales make up the whole of the open-market record (1 sale, €17k). The rest of the record consists of 1 share grant.

Most recently, on 5 December 2024, the filings show a transaction in RepliCel Life Sciences Inc. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.

Companies and markets linked to David M. Hall

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

RepliCel Life Sciences Inc. (CA)

Declarations17 total

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives26 Nov 2024RepliCel Life Sciences Inc.

0SEDI

295,291 sharesCommon SharesTSXSEDI:4413160

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives26 Nov 2024RepliCel Life Sciences Inc.

0SEDI

37,500 sharesConvertible Preferred Shares Class A Preference SharesTSXSEDI:4413159

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Feb 2023RepliCel Life Sciences Inc.

1,838 CAD13SEDI

17,500 shares@ CA$0.1050.4% of flowCommon SharesTSXSEDI:4070893

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives17 Jan 2023RepliCel Life Sciences Inc.

38,000 CAD12SEDI

422,222 shares@ CA$0.097.5% of flowCommon SharesTSXSEDI:4064286

◆

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives2 Jun 2021RepliCel Life Sciences Inc.

12,900 CAD13SEDI

33,506 shares@ CA$0.3852.7% of flowCommon SharesTSXSEDI:3755788

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives17 May 2021RepliCel Life Sciences Inc.

1,633 CAD11SEDI

4,355 shares@ CA$0.3750.3% of flowCommon SharesTSXSEDI:3751627

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives18 Aug 2020RepliCel Life Sciences Inc.

17,250 CAD15SEDI

95,833 shares@ CA$0.183.1% of flowCommon SharesTSXSEDI:3590821

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 Oct 2019RepliCel Life Sciences Inc.

14,250 CAD18SEDI

50,892 shares@ CA$0.2848.9% of flowCommon SharesTSXSEDI:3442346

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives22 Dec 2010RepliCel Life Sciences Inc.

0SEDI

Convertible Preferred Shares Class A Preference SharesTSXSEDI:3425977

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives13 Sept 2019RepliCel Life Sciences Inc.

15,000 CAD0SEDI

37,500 shares@ CA$0.4051.1% of flowConvertible Preferred Shares Class A Preference SharesTSXSEDI:3425979

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Jan 2019RepliCel Life Sciences Inc.

36,764 CAD12SEDI

77,398 shares@ CA$0.4757.5% of flowCommon SharesTSXSEDI:3302643

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives10 Aug 2016RepliCel Life Sciences Inc.

0SEDI

1,565,334 sharesCommon SharesTSXSEDI:3298685

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives31 May 2016RepliCel Life Sciences Inc.

72,000 CAD15SEDI

900,000 shares@ CA$0.0815.4% of flowCommon SharesTSXSEDI:2845324

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Jun 2016RepliCel Life Sciences Inc.

72,000 CAD15SEDI

480,000 shares@ CA$0.1515.3% of flowCommon SharesTSXSEDI:2845329

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives31 Mar 2016RepliCel Life Sciences Inc.

25,000 CAD12SEDI

125,000 shares@ CA$0.205.3% of flowCommon SharesTSXSEDI:2821783

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives31 Mar 2016RepliCel Life Sciences Inc.

100,000 CAD13SEDI

740,740 shares@ CA$0.13521.1% of flowCommon SharesTSXSEDI:2821774

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives5 Apr 2016RepliCel Life Sciences Inc.

125,000 CAD14SEDI

625,000 shares@ CA$0.2026.0% of flowCommon SharesTSXSEDI:2821789

17 of 17 declarations